A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis

Project: Research project

Project Details

StatusFinished
Effective start/end date11/16/2112/2/23

Funding

  • Heron Therapeutics: $5,500.00